Pilar Chacón

2.6k total citations
52 papers, 2.0k citations indexed

About

Pilar Chacón is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pilar Chacón has authored 52 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 19 papers in Epidemiology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pilar Chacón's work include Lipoproteins and Cardiovascular Health (17 papers), Acute Ischemic Stroke Management (14 papers) and Cerebrovascular and Carotid Artery Diseases (12 papers). Pilar Chacón is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Acute Ischemic Stroke Management (14 papers) and Cerebrovascular and Carotid Artery Diseases (12 papers). Pilar Chacón collaborates with scholars based in Spain, France and United Kingdom. Pilar Chacón's co-authors include José Álvarez‐Sabín, Joan Montaner, Carlos A. Molina, Manuel Quintana, Marc Ribó, Juan F. Arenillas, Anna Rosell, Àlex Rovira, Pilar Delgado and C. J. Gómez Ruiz and has published in prestigious journals such as Neurology, Diabetes Care and Stroke.

In The Last Decade

Pilar Chacón

52 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pilar Chacón Spain 24 879 624 403 397 376 52 2.0k
Shihong Zhang China 26 640 0.7× 362 0.6× 933 2.3× 224 0.6× 385 1.0× 75 2.4k
Tian Xu China 23 413 0.5× 263 0.4× 461 1.1× 342 0.9× 453 1.2× 112 1.6k
Francesca Papa Italy 13 956 1.1× 243 0.4× 252 0.6× 265 0.7× 241 0.6× 24 1.5k
Mona Skjelland Norway 29 671 0.8× 460 0.7× 804 2.0× 344 0.9× 487 1.3× 67 2.4k
Shinji Tanaka Japan 23 223 0.3× 603 1.0× 445 1.1× 633 1.6× 336 0.9× 72 2.2k
Jinxi Lin China 20 644 0.7× 299 0.5× 222 0.6× 217 0.5× 451 1.2× 79 1.6k
Djordje Radak Serbia 20 300 0.3× 590 0.9× 256 0.6× 442 1.1× 363 1.0× 122 1.6k
Milita Crisby Sweden 26 308 0.4× 373 0.6× 580 1.4× 1.1k 2.8× 504 1.3× 42 2.4k
Mišo Šabović Slovenia 25 306 0.3× 467 0.7× 237 0.6× 411 1.0× 822 2.2× 141 2.0k
Barbara Voetsch United States 19 556 0.6× 443 0.7× 250 0.6× 149 0.4× 207 0.6× 35 1.9k

Countries citing papers authored by Pilar Chacón

Since Specialization
Citations

This map shows the geographic impact of Pilar Chacón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Chacón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Chacón more than expected).

Fields of papers citing papers by Pilar Chacón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Chacón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Chacón. The network helps show where Pilar Chacón may publish in the future.

Co-authorship network of co-authors of Pilar Chacón

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Chacón. A scholar is included among the top collaborators of Pilar Chacón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Chacón. Pilar Chacón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chacón, Pilar. (2021). Los eSports, un punto y aparte en el patrocinio deportivo. 48–50. 1 indexed citations
2.
García‐Bonilla, Lidia, Dolors Giralt, David H. Salat, et al.. (2012). Evidence for the efficacy of statins in animal stroke models: a meta‐analysis. Journal of Neurochemistry. 122(2). 233–243. 66 indexed citations
3.
Massot‐Tarrús, Andreu, Anna Peñalba, Juan F. Arenillas, et al.. (2011). Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease. Atherosclerosis. 218(1). 181–187. 21 indexed citations
4.
Delgado, Pilar, Pilar Chacón, Anna Peñalba, et al.. (2011). Lipoprotein-Associated Phospholipase A<sub>2</sub> Activity Is Associated with Large-Artery Atherosclerotic Etiology and Recurrent Stroke in TIA Patients. Cerebrovascular Diseases. 33(2). 150–158. 30 indexed citations
5.
6.
Montaner, Joan, Maite Mendióroz, Marc Ribó, et al.. (2010). A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department. Journal of Internal Medicine. 270(2). 166–174. 57 indexed citations
7.
Montaner, Joan, David H. Salat, Teresa García‐Berrocoso, et al.. (2010). Reperfusion Therapy for Acute Stroke Improves Outcome by Decreasing Neuroinflammation. Translational Stroke Research. 1(4). 261–267. 9 indexed citations
8.
Domingues‐Montanari, Sophie, Israel Fernández‐Cadenas, Alberto Del Río-Espínola, et al.. (2010). The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals. European Journal of Neurology. 17(11). 1390–1392. 18 indexed citations
9.
Arenillas, Juan F., Andreu Massot‐Tarrús, José Álvarez‐Sabín, et al.. (2009). C-Reactive Protein Gene C1444T Polymorphism and Risk of Recurrent Ischemic Events in Patients with Symptomatic Intracranial Atherostenoses. Cerebrovascular Diseases. 28(1). 95–102. 20 indexed citations
10.
Balada, Eva, et al.. (2009). Changes in Lipid Profile Between Flare and Remission of Patients with Systemic Lupus Erythematosus: A Prospective Study. The Journal of Rheumatology. 36(8). 1639–1645. 11 indexed citations
11.
Montaner, Joan, Pilar Chacón, Jerzy Krupiński, et al.. (2007). Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. European Journal of Neurology. 15(1). 82–90. 104 indexed citations
12.
Montaner, Joan, Israel Fernández‐Cadenas, Carlos A. Molina, et al.. (2006). Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis. Stroke. 37(5). 1205–1210. 76 indexed citations
13.
Hernández, Cristina, et al.. (2005). Factores que influyen en la concentración plasmática de proteína C reactiva en la población diabética. Medicina Clínica. 124(9). 336–337. 5 indexed citations
14.
15.
Ruiz, C. J. Gómez, et al.. (2003). High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. Journal of Vascular Surgery. 38(5). 1018–1024. 98 indexed citations
16.
Hernández, Cristina, et al.. (2003). Biological Variation of Lipoprotein(a) in a Diabetic Population. Analysis of the Causes and Clinical Implications. Clinical Chemistry and Laboratory Medicine (CCLM). 41(8). 1075–80. 9 indexed citations
17.
Chacón, Pilar, et al.. (2000). Relationship Between Lipoprotein(a) Phenotypes and Plaminogen Activator Inhibitor Type 1 in Diabetic Patients. Thrombosis Research. 99(2). 119–127. 13 indexed citations
18.
Chacón, Pilar, et al.. (2000). Relationship of Lipoprotein(a) and Its Phenotypes with the Albumin Excretion Rate in Diabetic Patients: A Multivariate Analysis. ˜The œNephron journals/Nephron journals. 85(1). 27–33. 11 indexed citations
19.
Ibáñez, Lourdes, et al.. (1998). Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia. 41(9). 1057–1063. 134 indexed citations
20.
Simó, Rafael, et al.. (1997). Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non‐insulin‐dependent diabetes mellitus: protective effect of ‘null’ phenotype?. European Journal of Clinical Investigation. 27(6). 497–502. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shihong Zhang Breakdown of academic impact, for papers by Tian Xu Breakdown of academic impact, for papers by Francesca Papa Breakdown of academic impact, for papers by Mona Skjelland Breakdown of academic impact, for papers by Shinji Tanaka Breakdown of academic impact, for papers by Jinxi Lin Breakdown of academic impact, for papers by Djordje Radak Breakdown of academic impact, for papers by Milita Crisby Breakdown of academic impact, for papers by Mišo Šabović Breakdown of academic impact, for papers by Barbara Voetsch
Rankless by CCL
2026